Inmune Bio Files 8-K: Director Changes, Officer Appointments, Shareholder Votes
Ticker: INMB · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-appointment, director-change, shareholder-vote
TL;DR
Inmune Bio's 8-K shows director/officer changes, new appointments, and shareholder votes. Big governance shakeup.
AI Summary
On June 10, 2025, Inmune Bio, Inc. filed an 8-K report detailing several key events. These include the departure of directors or certain officers, the election of new directors, the appointment of certain officers, and updates on compensatory arrangements for officers. The filing also covers the submission of matters to a vote of security holders and other events, along with financial statements and exhibits.
Why It Matters
This filing indicates significant corporate governance changes and potential strategic shifts within Inmune Bio, Inc., which could impact its operational direction and shareholder value.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with votes by security holders, can signal shifts in strategy or internal dynamics that may carry inherent risks.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- June 10, 2025 (date) — Date of earliest event reported
FAQ
What specific items were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
Are there any new officer appointments mentioned in the filing?
Yes, the filing lists 'Appointment of Certain Officers' as an item of information, indicating new appointments have been made.
What is the principal executive office address for Inmune Bio, Inc.?
The principal executive offices are located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
When is the fiscal year end for Inmune Bio, Inc.?
The fiscal year end for Inmune Bio, Inc. is December 31st.
What is the SIC code for Inmune Bio, Inc.?
The Standard Industrial Classification (SIC) code for Inmune Bio, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding Inmune Bio, Inc. (INMB).